XML 31 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Revenue $ 35,186 $ 33,150 $ 67,827 $ 65,189
Cost of products sold 33,325 31,548 64,294 61,997
Gross margin 1,861 1,602 3,533 3,192
Operating expenses:        
Distribution, selling, general and administrative expenses 1,131 910 2,193 1,831
Restructuring and employee severance 21 7 153 16
Amortization and other acquisition-related costs 184 115 368 237
Impairments and loss on disposal of assets, net 68 9 68 12
Litigation (recoveries)/charges, net 58 19 90 20
Operating earnings 399 542 661 1,076
Other (income)/expense, net (5) 7 (4) 3
Interest expense, net 87 44 168 88
Loss on Extinguishment of Debt 0 0 2 0
Earnings before income taxes 317 491 495 985
Provision for/(benefit from) income taxes (736) 167 (675) 351
Net earnings 1,053 324 1,170 634
Net earnings attributable to noncontrolling interests 0 0 (2) (1)
Net earnings attributable to Cardinal Health, Inc. $ 1,053 $ 324 $ 1,168 $ 633
Earnings per common share attributable to Cardinal Health, Inc.:        
Basic (in shares) $ 3.35 $ 1.02 $ 3.70 $ 1.99
Diluted (in shares) $ 3.33 $ 1.02 $ 3.68 $ 1.97
Weighted-average number of common shares outstanding:        
Basic (in shares) 315 318 315 319
Diluted (in shares) 316 319 317 321
Cash dividends declared per common share $ 0.4624 $ 0.4489 $ 0.9248 $ 0.8978